Molecular Pharmacology
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of the International Journal of Molecular Sciences (IJMS) aims to rapidly publish novel data concerning molecular pharmacology. Pharmacology is a discipline which deals with the interaction of a drug of natural, semisynthetic or fully (bio)synthetic origin with the human or animal organism. Thus, it is positioned at the interface of pharmacy/chemistry and physiology/pathophysiology in their broadest sense. It operates at various organizational levels, such as the molecular, subcellular, cellular, organ, and systemic platforms. Molecular pharmacology investigates the molecular mode of action of drugs, among others using genetic and molecular biology methods, and in consequence, it is one of the most rapidly developing fields of pharmacology. We encourage submission of manuscripts that report significant advances on the molecular level in drug research but especially appreciate submissions which, in addition, follow up on the consequences of molecular changes on higher levels of organization.
Keywords
biochemical pharmacology; biomarkers; biosynthetics; chromosome; DNA structure; epigenetics; genetics; genomics; histology; individually tailored therapy; medicinal chemistry; medicine; membrane proteins; membrane transport; molecular biology; molecular pharmacology; pathophysiology; pharmacy; physiology; population genetics; proteomics; RNA structure; signal transduction; stem cells; transcriptional analyses; transgenic techniques; translational analyses
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Epilepsy Research and Antiepileptic Drugs, 2nd Edition (Deadline: 20 August 2025)
- Advances in Novel Anti-Alzheimer Drugs: Biological Target, Medicinal Chemistry and Formulation (Deadline: 20 August 2025)
- Advanced Research on the Adrenal Gland and Hormones (Deadline: 20 August 2025)
- Biomedical Applications of Mesenchymal Stem Cells (Deadline: 20 August 2025)
- Molecular Pharmacology of Medicinal Plants (Deadline: 20 August 2025)
- Molecular Advances in Liposome-Based Drug Delivery Systems (Deadline: 20 August 2025)
- Mechanistic and Small Molecule Discoveries for Therapeutic Advances in Hypertrophic and Dilated Cardiomyopathies (Deadline: 20 August 2025)
- Pharmacological Activities of Secondary Metabolites and Derivates of Medicinal Plants Around the World, 2nd Edition (Deadline: 20 August 2025)
- Drug Development Breakthroughs: From Novel Antimicrobials to Targeted Cancer Drugs (Deadline: 20 August 2025)
- Mechanistic Insights into Pharmacological and Non-Pharmacological Pain Therapies: From Cellular Responses to Therapy Outcomes (Deadline: 28 August 2025)
- Recent Advances in Molecular Pharmacology of Neurological Diseases (Deadline: 28 August 2025)
- Application and Formulation of Therapeutic Natural Deep Eutectic Solvents (Deadline: 29 August 2025)
- Molecular Pharmacology in Diabetes, 2nd Edition (Deadline: 30 August 2025)
- The Role of Natural Compound for Reversing Cancer Therapy Resistance (Deadline: 30 August 2025)
- Latest Advances in Computational Drug Discovery (Deadline: 30 August 2025)
- Glycoconjugates: From Structure to Therapeutic Application (Deadline: 31 August 2025)
- Advancements in Antioxidant Molecules: From Discovery to Therapeutic Applications (Deadline: 31 August 2025)
- Pharmacogenomics: The State of the Art and Future Perspectives (Deadline: 31 August 2025)
- Recent Approaches for Wound Treatment—2nd Edition (Deadline: 20 September 2025)
- New Insights into Anti-cancer Drug Discovery and Development (Deadline: 20 September 2025)
- Natural and Synthetic Compounds for Management, Prevention and Treatment of Obesity, 3rd Edition (Deadline: 20 September 2025)
- Advanced Synthetic Methodologies in Drug Development (Deadline: 20 September 2025)
- Advances in Epilepsy and Antiepileptic Drugs, 3rd Edition (Deadline: 20 September 2025)
- Drug Discovery: Design, Synthesis and Activity Evaluation (Deadline: 20 September 2025)
- Drug Resistance Mechanisms in Human Cancer Cells to Anticancer Drugs (Deadline: 20 September 2025)
- Editorial Board Members’ Collection Series: Pain (Deadline: 20 September 2025)
- Small Molecule Drug Design and Research: 3rd Edition (Deadline: 20 September 2025)
- The Future of Drug Discovery and Development, 2nd Edition (Deadline: 20 September 2025)
- Advances in Polymers and Polysaccharides in Delivery Systems (Deadline: 20 September 2025)
- TRP Channel, 2nd Edition (Deadline: 20 September 2025)
- Application of Natural Products in Biomedicine and Pharmacotherapy: 2nd Edition (Deadline: 20 September 2025)
- Role of Natural Products in Health and Diseases (Deadline: 20 September 2025)
- Molecular Insights on Drug Discovery, Design, and Treatment (Deadline: 20 September 2025)
- Research and Recent Advances of Antimicrobials (Deadline: 20 September 2025)
- Drug Discovery and Development Focusing on Natural Products (Deadline: 20 September 2025)
- New Anti-cancer Agents: Design, Synthesis and Applications (Deadline: 20 September 2025)
- Antimicrobial Resistology: A New Approach in the Fight Against Antimicrobial Resistance (Deadline: 20 September 2025)
- The Role of Natural Products in Inflammation (Deadline: 20 September 2025)
- Molecular Pharmacology of Cardiovascular Disease, 2nd Edition (Deadline: 30 September 2025)
- Drug Repurposing in Rare Diseases: From Molecular Insights to Patient Benefits (Deadline: 30 September 2025)
- Lipid Emulsion and Other Treatment in Drug Toxicity (Deadline: 30 September 2025)
- Metallopharmaceuticals: Current Trends and Future Perspectives in Cancer Immunoediting (Deadline: 30 September 2025)
- Drug Repurposing: Emerging Approaches to Drug Discovery (2nd Edition) (Deadline: 30 September 2025)
- Antimicrobial Agents and the Quest for Resistance Breakthroughs (Deadline: 30 September 2025)
- New Insights into Chemotherapeutic Agents in Cancer Treatment (Deadline: 30 September 2025)
- Natural Bioactive Compounds for Human Health, 3rd Edition (Deadline: 30 September 2025)
- Drug Discovery: Natural Products and Compounds (Deadline: 15 October 2025)
- Recent Research on Novel Lipid-Based Nano Drug Delivery Systems (Deadline: 20 October 2025)
- Latest Advances in Protein-Ligand Interactions (Deadline: 20 October 2025)
- Hormone/Receptor System in Human Diseases (Deadline: 20 October 2025)
- Molecular Pharmacology and Metabolic Signaling in Health and Disease (Deadline: 20 October 2025)
- Antituberculous Drugs: Progress and Challenges (Deadline: 20 October 2025)
- Synthesis and Molecular Research of Drugs for Skin Diseases and Cosmetic Ingredients (Deadline: 20 October 2025)
- Research on Drug Metabolism and Disposition (Deadline: 20 October 2025)
- Bioactive Peptides: Synthesis, Functions, and Medicinal Chemistry Applications (Deadline: 20 October 2025)
- Nose-to-Brain Drug Delivery: Opportunities and Challenges (Deadline: 20 October 2025)
- Newer Pharmacological Treatment Concepts for Patients with Acute Coronary Syndrome (Deadline: 20 October 2025)
- New Advances in Opioid Research (Deadline: 20 October 2025)
- The Activity and Underlying Mechanisms of Anticancer Drugs (Deadline: 20 October 2025)
- Novel Approaches in Drug Discovery: From Natural Products to Therapeutic Innovations (Deadline: 20 October 2025)
- Emerging Topics in Metal Complexes: Pharmacological Activity, 2nd Edition (Deadline: 30 October 2025)
- Advanced Research in Veterinary Drugs (Deadline: 30 October 2025)
- Recent Advances in Computer-Aided Drug Design (Deadline: 30 October 2025)
- Molecular Advances on Cannabinoid and Endocannabinoid Research, 3rd Edition (Deadline: 30 October 2025)
- Proteolysis-Targeting Chimeras (PROTACs) in Drug Design (Deadline: 31 October 2025)
- G Protein-Coupled Receptors: Signaling, Regulation and Therapeutic Opportunities, 2nd Edition (Deadline: 31 October 2025)
- Lipopolysaccharide as a Drug Target (Deadline: 31 October 2025)
- Antiviral Drug Targets: Structure, Function, and Drug Design—3rd Edition (Deadline: 31 October 2025)
- 3D Printing in Pharmaceutical Drug Delivery (Deadline: 31 October 2025)
- Molecular Computational Research in Pharmacological Structure–Efficacy (Deadline: 31 October 2025)
- Advances in Photodiagnosis and Photodynamic Therapy (Deadline: 31 October 2025)
- Innovative Approaches in Personalized Medicine: Cancer, Inherited Diseases, and Beyond (Deadline: 10 November 2025)
- Drug Treatment for Bacterial Infections (Deadline: 20 November 2025)
- Drug Design and Development for Neurological Diseases (Deadline: 20 November 2025)
- Structure–Activity Relationships Within Pharmaceutical Interactions and the Discovery of Molecular Targets (Deadline: 20 November 2025)
- Synthesis and Application of Chiral Ligands and Heterocycles in Pharmacological Studies (Deadline: 20 November 2025)
- Medicinal Plants and Natural Compounds in Health and Disease: Progresses, Challenges, Opportunities, 2nd Edition (Deadline: 20 November 2025)
- Molecular Pharmacological Advances in Gastrointestinal Health (Deadline: 20 November 2025)
- Pharmacology and Toxicology of Synthetic and Natural Products (Deadline: 20 November 2025)
- Natural Products and Synthetic Compounds for Drug Development: 3rd Edition (Deadline: 20 November 2025)
- Anticancer, Antioxidant, and Anti-Inflammatory Properties of Natural Products (Deadline: 20 November 2025)
- Molecular Research on Potential New Antidepressant Drugs (Deadline: 20 November 2025)
- New Insights in Artificial Intelligence for Drug Design and Target Discovery (Deadline: 20 November 2025)
- Antibacterial Activity of Novel Antimicrobial Agents (Deadline: 20 November 2025)
- Advances in Organic Synthesis in Drug Discovery (Deadline: 20 November 2025)
- Research on Synthetic Medicinal Chemistry (Deadline: 20 November 2025)
- Macrophage Polarization and Human Inflammatory Diseases (Deadline: 30 November 2025)
- Molecular Mechanisms in Mitochondria-Targeted Drug Delivery System (Deadline: 30 November 2025)
- Molecular Modeling in Pharmaceutical Sciences (Deadline: 30 November 2025)
- In Silico Approaches to Unravelling Toxicity Mechanisms in Molecular Drugs (Deadline: 30 November 2025)
- Natural Product Therapies in Cancer (Deadline: 30 November 2025)
- Topoisomerase Inhibitors: Future Perspectives and Challenges (Deadline: 20 December 2025)
- Molecular Mechanisms and Therapeutic Approaches to Osteoarthritis (Deadline: 20 December 2025)
- RNA Vaccines and Therapeutics: Challenges and Opportunities (Deadline: 20 December 2025)
- Insights into Redox Homeostasis and Oxidative Stress (Deadline: 20 December 2025)
- Anticancer Antibiotics: Progresses, Opportunities and Challenges (Deadline: 20 December 2025)
- New Advances in Radiopharmaceuticals and Radiotherapy (Deadline: 20 December 2025)
- Antifungal Drug Discovery: Progresses, Challenges, Opportunities, 2nd Edition (Deadline: 20 December 2025)
- Pharmacokinetics of Psychoactive Substances: Molecular and Forensic Aspects (Deadline: 20 December 2025)
- The Role of Natural Products in Drug Discovery (Deadline: 20 December 2025)
- From Nature to Medicine: Exploring Natural Products for New Therapies (Deadline: 20 December 2025)
- Development and Validation of New Analytical Methods for the Determination of Drugs and Their Metabolites (Deadline: 20 December 2025)
- Drug Delivery Systems in Veterinary Medicine: Innovations and Applications (Deadline: 20 December 2025)
- Molecular Pharmacology of Cation-Permeable Ion Channels (Deadline: 20 December 2025)
- Cancer Drug Treatment and Cancer Cell Drug Resistance (Deadline: 20 December 2025)
- Structural Characterization and Pharmacological Activity of Natural Compounds (Deadline: 20 December 2025)
- Advances in Drug Delivery Systems: From Nanoparticles to Precision Medicine (Deadline: 30 December 2025)
- Gene-Level Pharmacological Research on Natural Products (Deadline: 30 December 2025)
- Molecular Insight into Antimicrobial Resistance (Deadline: 30 December 2025)
- The Impact of Natural Bioactive Compounds on Human Health and Disease (Deadline: 31 December 2025)
- Advancements in Diagnostic and Preventive Pharmacogenomics (Deadline: 31 December 2025)
- Natural Products in Drug Discovery and Development (Deadline: 31 December 2025)
- Enzymes and Enzyme Inhibitors—Applications in Medicine and Diagnosis, 3rd Edition (Deadline: 31 December 2025)
- Synthesis and Structural Studies of Potential Anticancer Drugs (Deadline: 31 December 2025)
- Advances in Drug Synthesis Reactions: From Bench to Breakthroughs (Deadline: 31 December 2025)
- 25th Anniversary of IJMS: Updates and Advances in Molecular Pharmacology (Deadline: 31 December 2025)
- Pharmacological Agents for Soft Tissue and Articular Injections: From Mechanisms to Clinical Applications (Deadline: 31 December 2025)
- Advances in Pharmacology for Neuropathic and Chronic Pain Management (Deadline: 31 December 2025)
- Targeted Pharmacological Modulation of Cellular Pathology and Drug Discovery: A Translational Approach to Bridge Laboratory Discoveries with Clinical Practice (Deadline: 31 December 2025)
- Anticancer Drugs: Current Status and Future Directions (Deadline: 31 December 2025)
- Cell Penetrating Peptides: Novel Therapeutic Tools for Drug Delivery (Deadline: 31 December 2025)
- Anti-Cancer Effects of Natural Products: 2nd Edition (Deadline: 31 December 2025)
- Natural-Derived Bioactive Compounds in Disease Treatment (Deadline: 20 January 2026)
- Recent Advances of Novel Pharmaceutical Designs for Anti-Cancer Therapies, 3rd Edition (Deadline: 20 January 2026)
- Advances in Drug Discovery and Synthesis: 2nd Edition (Deadline: 20 January 2026)
- Drug Discovery and Development for Renal Disease Treatment (Deadline: 20 January 2026)
- Drug Delivery Systems and Treatment of Human Diseases: Prospects and Challenges (Deadline: 20 January 2026)
- Advances and Emerging Trends in Marine Natural Products (Deadline: 20 January 2026)
- The Role of Bioactive Natural Products in Human Health (Deadline: 20 January 2026)
- Innovative Strategies in the Design and Development of Anticancer Agents (Deadline: 20 January 2026)
- New Progress in Peptide Drugs (Deadline: 31 January 2026)
- Natural Products and Compounds in Anticancer Drug Discovery (Deadline: 31 January 2026)
- Ion Channels as Therapeutic Target: Drug Design and Pharmacological Investigation (3rd Edition) (Deadline: 31 January 2026)
- Drug Therapy of Systemic Lupus Erythematosus (Deadline: 20 February 2026)
- Biosynthesis of Phytochemicals and Their Applications in Novel Drug Lead Development (Deadline: 20 February 2026)
- Drug Discovery Based on Natural Products (Deadline: 28 February 2026)
- Molecular Pharmacology of Protein Kinase Inhibitor (Deadline: 20 March 2026)
- Synthetic Chemistry in Drug Discovery (Deadline: 20 April 2026)
- Techniques and Strategies in Drug Design and Discovery, 3rd Edition (Deadline: 20 April 2026)
Topical Collections
Following topical collections within this section are currently open for submissions:
